<HashMap><database>GEO</database><file_versions><headers><Content-Type>application/xml</Content-Type></headers><body><files><Other>ftp://ftp.ncbi.nlm.nih.gov/geo/series/GSE274nnn/GSE274016/</Other></files><type>primary</type></body><statusCode>OK</statusCode><statusCodeValue>200</statusCodeValue></file_versions><scores/><additional><omics_type>Transcriptomics</omics_type><species>Mus musculus</species><gds_type>Expression profiling by high throughput sequencing</gds_type><full_dataset_link>https://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE274016</full_dataset_link><repository>GEO</repository><entry_type>GSE</entry_type></additional><is_claimable>false</is_claimable><name>Nuclear receptor Nur77 resolves the inflammatory response of macrophages primarily by cis- and trans-regulation of AP-1 target genes [RNA-Seq]</name><description>The nuclear receptor Nur77 plays a crucial, protective role in chronic inflammatory diseases and deficiency of Nur77 in macrophages results in excessive pro-inflammatory cytokine secretion. Previous research suggested that Nur77's regulatory function in inflammation is due to repression of the pro-inflammatory transcription factor NF-ĸB, but the underlying mechanism remains unclear. To address this, we applied a genome-wide, multi-omics approach in LPS-stimulated RAW264.7 macrophages with inducible Nur77 expression. Key findings were validated in wild-type and Nur77-deficient bone marrow-derived macrophages. We show that Nur77 suppresses the expression of inflammatory genes through a dual mechanism wherein Nur77 acts as a repressor of AP-1 targets at two levels: First, Nur77 occupies regulatory elements proximal to AP-1 target genes through AP-1 motifs and second, Nur77 regulates the expression of AP-1 family members themselves. These repressive activities of Nur77 result in diminished RNA Pol II on AP-1 genes and their targets. The first zinc finger of the Nur77 DNA-binding domain is required to reduce AP-1 activity. In summary, Nur77 represses macrophage inflammation through regulation of both immediate-early AP-1 expression, as well as inhibition of AP-1-driven gene programs.</description><dates><publication>2026/07/28</publication></dates><accession>GSE274016</accession><cross_references><GSM>GSM8441843</GSM><GSM>GSM8441854</GSM><GSM>GSM8441853</GSM><GSM>GSM8441842</GSM><GSM>GSM8441856</GSM><GSM>GSM8441845</GSM><GSM>GSM8441834</GSM><GSM>GSM8441855</GSM><GSM>GSM8441844</GSM><GSM>GSM8441850</GSM><GSM>GSM8441841</GSM><GSM>GSM8441852</GSM><GSM>GSM8441851</GSM><GSM>GSM8441840</GSM><GSM>GSM8441839</GSM><GSM>GSM8441836</GSM><GSM>GSM8441847</GSM><GSM>GSM8441835</GSM><GSM>GSM8441846</GSM><GSM>GSM8441857</GSM><GSM>GSM8441838</GSM><GSM>GSM8441849</GSM><GSM>GSM8441848</GSM><GSM>GSM8441837</GSM><GPL>24247</GPL><GSE>274016</GSE><taxon>Mus musculus</taxon><PMID>[42605805]</PMID></cross_references></HashMap>